AR and breast cancer: It has been demonstrated that inhibition of USP14-mediated androgen receptor (AR) deubiquitination contributes to the downregulation of AR proteins and suppression of AR-related signaling pathways, such as Wnt/β-catenin in breast cancer (Liao et al., 2018; Xia et al., 2019).